A Questionnaire Assessing the Involvement of Toxicologists in Metabolism and Kinetics

  • W. Riess
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 8)


Modern toxicological risk assessment requires that pathological signs and symptoms are correlated with chemically defined terms of exposure of the biological system to the agents. The frontiers of this interdisciplinary collaboration of chemistry and toxicology are well marked (See references). The question is, do the majority of toxicologists accept and use these modern principles.


Pathological Sign Interdisciplinary Collaboration Concentration Kinetic Good Laboratory Practice Toxicological Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Clark B, Smith DA (1984) “Pharmacokinetics and Toxicity Testing” CRC Critical Review in Toxicology 12, 343–385CrossRefGoogle Scholar
  2. Davis M (1982) “Drug Reactions and the Liver” Advances Drug React. Ac. Pois. Rev. 1, 1–33Google Scholar
  3. Doull J (1984) “The Past, Present and Future of Toxicology” Pharmacol. Reviews 36, 15S - 18SGoogle Scholar
  4. Nau H (1983) “The Role of Delivery Systems in Toxicology and Drug Development” Pharmacy International 4, 228–231Google Scholar
  5. Smyth RD, Hottendorf GH (1980) “Application of Pharmacokinetics and Biopharmaceutics in the Design of Toxicological Studies” Toxicology and Applied Pharmacology, 53, 179–195PubMedCrossRefGoogle Scholar
  6. Traina VM (1983) “The Role of Toxicology in Drug Research and Drug Development” Medicinal Research Reviews 3, 43–72PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • W. Riess
    • 1
  1. 1.Ciba-Geigy LtdBaselSwitzerland

Personalised recommendations